Back to search

Article

A Novel Neutralizing Antibody Targeting Receptor Binding Domain of SARS-CoV-2

2020-09-10

Abstract excerpt

<title>Abstract</title> <p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the current COVID-19 global pandemic. Vaccines and therapeutics are urgently needed for this highly transmissible virus. In this study, we screened human monoclonal antibodies (mAbs) targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike protein from an antibody library constructed from peripheral blood...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b00e4632-3e9f-562a-b62b-c4803458f0fe
DOI
10.21203/rs.3.rs-59639/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Novel Neutralizing Antibody Targeting Receptor Binding Domain of SARS-CoV-2DOI 10.21203/rs.3.rs-59639/v1
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike proteinSemantic proximity
Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding DomainSemantic proximity
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodiesSemantic proximity
SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy.Semantic proximity
Isolation and characterization of neutralizing monoclonal antibodies from a large panel of murine antibodies against RBD of the SARS-CoV-2 Spike proteinSemantic proximity
Broad Neutralization Activity of SARS-CoV-2 Antibody is Achieved by Coordinated Recognition of Virus Vulnerable SiteSemantic proximity
A human monoclonal antibody targeting a conserved pocket in the SARS-CoV-2 receptor-binding domain coreSemantic proximity
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infectionSemantic proximity
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes.Semantic proximity
A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2Semantic proximity
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic AntibodiesSemantic proximity
An <i>in vitro</i> experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodiesSemantic proximity
Select a neighboring publication to make it the new centre.